Exclusive-FDA Drug Center Head Expected to Leave After Commissioner's Exit, Sources Say

The acting head of the U.S. Food and Drug Administration’s drug center, Tracey Beth Hoeg, is expected to leave the agency just days after Commissioner Marty ⁠Makary…
Reuters Health Information

Source link : https://www.medscape.com/s/viewarticle/exclusive-fda-drug-center-head-expected-leave-after-2026a1000ftz?src=rss

Author :

Publish date : 2026-05-15 15:49:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

Exclusive-FDA Drug Center Head Expected to Leave After Commissioner’s Exit, Sources Say

First test of CO2 removal with green sand finds no harm to marine life

Debate: Fast or Slow Correction of Chronic Hyponatremia?

Related Posts

I tried the UK’s ‘saltiest’ sandwich – here’s what I learned

GLP-1 Drug Makes Its Case for Treating Plaque Psoriasis

FDA Approves ctDNA-Guided Atezolizumab for Bladder Cancer

Many States Not Prepared to Respond to Public Health Emergencies, Report Finds

Largest U.S. Children’s Hospital to Set Up a ‘Detransition Clinic’ for Trans Youth

How a Challenge to Mifepristone Could Disrupt Drug Regulation at Large

I tried the UK’s ‘saltiest’ sandwich – here’s what I learned

GLP-1 Drug Makes Its Case for Treating Plaque Psoriasis

FDA Approves ctDNA-Guided Atezolizumab for Bladder Cancer

Many States Not Prepared to Respond to Public Health Emergencies, Report Finds

Largest U.S. Children’s Hospital to Set Up a ‘Detransition Clinic’ for Trans Youth

How a Challenge to Mifepristone Could Disrupt Drug Regulation at Large

Hantavirus Strain in Outbreak Hasn’t Become More Transmissible, WHO Says

What we know about the Reading Meningitis B cases

Categories

Archives